Recent Posts
- PPMD Provides $250,000 in Funding to Secretome Therapeutics Through PPMD Venture Pathways Program to Support Development of Cardiac Cell Therapy
- Secretome Therapeutics to Present at the 2026 J.P. Morgan Healthcare Conference
- Secretome Therapeutics Initiates Phase 1 Clinical Trial of STM-01 in Patients with Dilated Cardiomyopathy
- RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01
- Secretome Therapeutics Awarded $400,000 Grant from Friedreich’s Ataxia Research Alliance (FARA)